Manzo Pharmaceut Financials

Based on the key indicators related to Manzo Pharmaceut's liquidity, profitability, solvency, and operating efficiency, Manzo Pharmaceut is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January. At this time, Manzo Pharmaceut's Total Stockholder Equity is very stable compared to the past year. As of the 18th of December 2024, Net Tangible Assets is likely to grow to 1,470, while Total Assets are likely to drop about 164.5 K.
The financial analysis of Manzo Pharmaceut is a critical element in measuring its lifeblood. Investors should not minimize Manzo Pharmaceut's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(43,764.63)

  

Manzo Pharmaceut Stock Summary

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania. Manzo Pharmaceuticals operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 12 people.
Specialization
Financial Services, Financial Services
InstrumentUSA Stock View All
ExchangeOTCCE Exchange
ISINUS56510D1063
Business AddressPO Box 107,
SectorCapital Markets
IndustryFinancials
BenchmarkDow Jones Industrial
Websitewww.lactofreedom.com
Phone570 249 6000
CurrencyUSD - US Dollar

Manzo Pharmaceut Key Financial Ratios

Manzo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Manzo Pharmaceut's current stock value. Our valuation model uses many indicators to compare Manzo Pharmaceut value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Manzo Pharmaceut competition to find correlations between indicators driving Manzo Pharmaceut's intrinsic value. More Info.
Manzo Pharmaceut is rated top company in current valuation category among its peers. It also is considered to be number one stock in shares outstanding category among its peers creating about  100,002  of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Manzo Pharmaceut's earnings, one of the primary drivers of an investment's value.

Manzo Pharmaceut Systematic Risk

Manzo Pharmaceut's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Manzo Pharmaceut volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Manzo Pharmaceut correlated with the market. If Beta is less than 0 Manzo Pharmaceut generally moves in the opposite direction as compared to the market. If Manzo Pharmaceut Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Manzo Pharmaceut is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Manzo Pharmaceut is generally in the same direction as the market. If Beta > 1 Manzo Pharmaceut moves generally in the same direction as, but more than the movement of the benchmark.
When determining whether Manzo Pharmaceut offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Manzo Pharmaceut's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Manzo Pharmaceut Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Manzo Pharmaceut Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Manzo Pharmaceut. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Manzo Pharmaceut. If investors know Manzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Manzo Pharmaceut listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Manzo Pharmaceut is measured differently than its book value, which is the value of Manzo that is recorded on the company's balance sheet. Investors also form their own opinion of Manzo Pharmaceut's value that differs from its market value or its book value, called intrinsic value, which is Manzo Pharmaceut's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Manzo Pharmaceut's market value can be influenced by many factors that don't directly affect Manzo Pharmaceut's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Manzo Pharmaceut's value and its price as these two are different measures arrived at by different means. Investors typically determine if Manzo Pharmaceut is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Manzo Pharmaceut's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.